Amgen Stake Reduced by Korea Investment CORP Amid Shift in Hedge Fund Holdings
Korea Investment CORP reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 31.8% in Q2, according to a recent SEC filing.
The fund sold 126,006 shares during the quarter and now owns 269,926 shares of Amgen's stock, valued at $97,746,000.
This reduction is part of a larger trend, as other hedge funds and institutional investors have also adjusted their positions in Amgen recently.